Allman Rollins, MD
Advanced Heart Failure and Transplant Cardiology · Falls Church, VANPI 1205256013
Payments from drug & device makers
What this record shows
Cvrx, Inc. accounts for 66.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $3,657 and has fallen 56.9% since, to $1,578 in 2025.
Across 52 payments — averaging $167.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$6K
- Abbott$3K
- Abiomed$253
- Lexicon Pharmaceuticals, Inc.$68
What the payments were for
- Travel & lodging$4,64853%
- Food & beverage$4,06347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 28 | $5,751 |
| Abbott | 18 | $2,640 |
| Abiomed | 4 | $253 |
| Lexicon Pharmaceuticals, Inc. | 2 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,712 in reported general payments places this provider in the 60th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.
See all advanced heart failure and transplant cardiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 85 | $108,839 |
| EntrestoSacubitril/Valsartan | 71 | $90,321 |
| EliquisApixaban | 21 | $26,680 |
| Isosorbide Dinitrate | 12 | $4,067 |
| Eplerenone | 19 | $2,213 |
| Metoprolol Succinate | 71 | $1,030 |
| Torsemide | 23 | $567 |
| Spironolactone | 87 | $472 |
| Warfarin Sodium | 28 | $360 |
| Atorvastatin Calcium | 46 | $264 |
| Losartan Potassium | 28 | $262 |
| Carvedilol | 41 | $163 |
| Hydralazine Hcl | 11 | $111 |
| Furosemide | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Falls Church
- Palak ShahFalls Church$112K
- Shashank DesaiFalls Church$80K
- Michael FlanaganFalls Church$29K
- Lauren CooperFalls Church$21K
- Iyad IssehFalls Church$6K
- Jamie KennedyFalls Church$4K
- Timothy WelchFalls Church$4K
- Lena AliFalls Church$2K
- Vanessa BlumerFalls Church$2K
- Amin YehyaNorfolk$398K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.